1Mehta SR, Bassm~d JP, Chrolavicius S, et al. Design and rationale of CURRENT-OASIS 7:a randomized,2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy[J]. Am Heart J,2008,156:1080-1088.
2A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). ACC/ AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction:Executive Summary [ J ]. Circulation, 2007,116 : 803-877.
3van de Werf,Frans Bax,Jeroen Betriu,et al. Management of acute myocardial infarction in patients presenting with persistent ST-sagment elevation:the task force on the management of ST-segment elevation acute myocardial infarction of the european society of cardiology [ J ]. European Heart Journal, 2008,29 : 2909-2945.
4Bassand,Jean-Pierre. Hamm, Christian W Ardissino,et al.Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of Non-ST-Segment elevation acute coronary syndromes of the european society of cardiology [J]. European Heart Journal Advance Access published, 2007,8 : 599-675.
5Stephen D,Wiviott,Elliott M,et al. Randomized Comparison of Prasugrel (CS-747, LY640315 ), a Novel Thienopyridine P2Y12 Antagonist,With Clopidogrel in Percutaneous Coronary Intervention: results of the joint utilization of medications to block platelets optimally (JUMBO)-TIMI 26 trial [J]. Circulation,2005,111:3366- 3373.
6Jakubowski JA,Winters KJ,Naganuma H,et al. Prasugrel,a novel thienopyridine antiplatelet agent :A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile [ J ]. Cardiovasc Drug Rev, 2007,25 : 357-374.
7Wallentin L, Becker RC,Budaj A,et al. Ticagrelor versus Clopidogrel in patients with acute coronary syndromes [J]. N Engl J Med, 2009,361 : 1045-1057.
8Bhatt DL,Lincoff AM,Gibson CM,et al. Intravenous platelet blockade with cangrelor during PCI [J]. N Engl J Med,2009,361: 2330-2341.
5Mielniczuk LM, Pfeffer MA, Lewis EF, et al. Estimated glomerular filtration rate,inflammation and cardiovascular events after an acute coronary syndrome[J]. Am Heart J, 2009,155(4):725-731.
